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ABSTRACT 
 
 
 
 
 Since the endocochlear potential (EP) cannot be measured in humans, 
mouse models offer a useful way to investigate the pathophysiology of strial 
presbycusis and to potentially identify responsible genes.  Two inbred strains of 
mice (C57BL/6J and BALB/cJ) have been shown to differ in terms of the EP and 
strial anatomical correlates.  In contrast to C57BL/6J (B6) mice, BALB/cJ 
(BALB) mice have a lower EP, which coincides with a decreased number of 
marginal cells and a thinner spiral ligament in BALBs.  To further investigate this 
relationship, and estimate the number of gene(s) responsible for the lower EP in 
BALBs, 11 recombinant inbred (RI) strains created from crosses between B6 and 
BALB mice were examined.  Cochlear morphometric data gathered for the RI 
strains suggest that the responsible genes most prominently influence marginal 
cell density in the stria vascularis.  Analysis of EP data using WebQTL online 
mapping utility revealed a suggestive linkage to a ~7Mb segment of Chromosome 
12 (provisionally named Nvep1) and a suggestive linkage to Chromosome 15 
(Nvep2).  Analysis of marginal cell data using WebQTL revealed a suggestive 
linkage to the same ~7Mb segment of Chromosome 12 (Nvep1).  Since Nvep1 
maps to same general location as does marginal cell density, this supports the 
suggestion that subtle differences in marginal cell density (or a related property) 
in part determine the EP.  Since marginal cell density corresponds to both the 
 iii 
‘low normal’ EP in young BALBs as well as age-associated EP decline in 
BALBs, the Nvep1 region may encompass a ‘strial presbycusis’ predisposing 
gene.  
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
 
Age-related hearing loss (ARHL), or presbycusis, is caused by the gradual 
degeneration of the auditory system over time, and is one of the most common chronic 
conditions affecting the aging population (Moscicki, Elkins, Baum, & McNamara, 1985; 
Cruickshanks, Wiley, Tweed, Klein, B., Klein R., & Mares-Perlman et al., 1998).  
According to the National Institute on Deafness and Other Communication Disorders 
(2001), 30-35% of adults over 65 have a hearing loss, with the prevalence increasing to 
40-50% for individuals 75 and older.  The number of individuals affected by this 
condition continues to grow with increases in lifespan and population growth.  In the 
United States specifically, it is estimated that there will be 71 million adults over the age 
of 65 by 2030 (Center for Disease Control, 2007).  A large proportion of this growing 
aging population will have ARHL, increasing the need for prevention and treatments that 
address communication difficulties posed by presbycusis. 
Presbycusis may cause significant communication difficulties and a reduced 
quality of life, which can be partially managed by hearing aids, cochlear implants and 
assistive listening technology (Chisolm, Johnson, Danhauer, Portz, Abrams, & Lesner et 
al., 2007; Maillet, Tyler, & Jordan, 1995).  It is well-documented that hearing loss is 
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associated with psychosocial dysfunction, fatigue, depression, and withdrawal from 
social situations (Heine & Browning, 2002; Mulrow, Aguilar, Endicott, Tuley, Velez, 
Charlip et al., 1990; Kochkin, 2007).  Hearing aids and other assistive devices can 
ameliorate communication difficulties associated with presbycusis (Mulrow et al., 1990; 
Chisolm et al., 2007).  Despite the fact that hearing aids are capable of improving 
communication ability and quality of life for those with hearing loss, only about 20% of 
individuals who could benefit from hearing aids use them (Kochkin, 2007).  Reluctance 
to use hearing aids is commonly based on factors such as cost, a perceived lack of 
benefit, and perceived stigma associated with the use of assistive devices (Kochkin, 
1993).  The fact that hearing aids are only used by a small fraction of those who could 
benefit from them increases the urgency of finding alternative therapies to prevent or 
treat presbycusis.   
Although hearing aids and other assistive technology can improve the quality of 
life for individuals with presbycusis, there is currently no technology that can match the 
extraordinary processing capability of the normal auditory system and restore natural 
hearing.  It is not surprising that assistive technology does not completely correct hearing 
difficulties experienced by those with presbycusis, considering the complexity of the 
auditory system.  ARHL typically affects the sensorineural processing of the auditory 
system that is responsible for transducing acoustic input into complex electrical impulses 
that are transmitted to the auditory cortex in the temporal lobe of the brain (Musiek & 
Baran, 2007).  The healthy cochlea contains approximately 15,000 sensory hair cells 
which are responsible for processing incoming sound and transducing the information 
into electrical impulses.  Presbycusis can result from the degeneration of both the sensory 
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and supporting cells of the cochlea, resulting in a loss of the filtering and transmission of 
incoming sound (Chisolm, Willott, & Lister, 2003).  The most advanced hearing aid 
technology is not able to replace the exquisitely complex processing of the normal 
sensorineural system.  While researchers interested in hearing aid technology continue to 
create more sophisticated devices to treat hearing loss, the issue of presbycusis is also 
being addressed from the vantage point of research in basic hearing science.  A better 
understanding of the pathology underlying presbycusis may offer ways to treat or prevent 
the condition altogether.  Potential treatments or preventative measures could come in the 
form of pharmacological interventions or even gene therapy if the genetic determinants of 
presbycusis are uncovered.   
Types of Presbycusis 
Presbycusis refers to hearing loss due to any age-related degeneration of the 
auditory system, and it is generally accepted that there are several distinct forms of 
presbycusis caused by separate pathologies.  The most widely accepted framework of 
presbycusis was described by Schuknecht in 1964 and separates ARHL into three main 
forms: sensory, neural, and strial presbycusis.  These classifications were later confirmed 
by Schuknecht’s histologic analysis of 21 human temporal bones, which demonstrated 
that individuals with ARHL typically exhibited degeneration of one cochlear cell type 
(sensory, neural, or strial) that outpaced other peripheral deterioration (Schuknecht & 
Gacek, 1993).  Although this organizational scheme is generally supported by animal 
models (Ohlemiller, 2006), there is currently no consensus regarding how many separate 
types of ARHL exist or which clinical findings characterize each pathology. 
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Sensory Presbycusis 
Sensory presbycusis is thought to be caused by a degeneration of the sensory and 
supporting cells within the organ of Corti (Schuknecht, 1964).  The sensory mechanism 
of the cochlea is comprised of approximately 3,500 outer hair cells (OHCs) and 12,000 
inner hair cells (IHCs) which are responsible for processing and transducing incoming 
sound signals into electrochemical impulses that can be conducted to the auditory cortex 
via the 8
th
 nerve (Musiek et al., 2007).  The degeneration of the sensory structures 
typically begins with the OHCs in the basal portion of the cochlea (Spongr, Flood, 
Frisina, & Salvi, 1997).  The audiometric findings associated with sensory ARHL are 
thought to include a high frequency sensorineural hearing loss with relatively good word 
recognition scores (Schuknecht, 1974; Schuknecht et al., 1993).   The fact that basal 
sensory structures, and OHCs in particular, are also susceptible to damage from noise-
exposure and ototoxins makes sensory ARHL one of the most difficult forms of 
presbycusis to distinguish from injury-related pathology (Ohlemiller & Frisina, 2008)  
Neural Presbycusis 
 Neural ARHL is characterized by a degeneration of spiral ganglion cells that 
outpaces the loss of sensory and supporting structures in the organ of Corti (Schuknecht, 
1974).  Neuronal loss tends to occur equally throughout the length of the cochlea, and 
involves the deterioration of the soma, axon, and dendrites of the cells (Chisolm et al., 
2003).  The clinical findings in cases of neuronal hearing loss usually involve a gradual 
or steeply sloping sensorineural loss, with word recognition that is disproportionately 
poor compared to pure tone thresholds (Schuknecht, 1974).  Although this is considered 
to be the classic audiometric profile of neural presbycusis, neither pure tone thresholds 
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nor word recognition results offers a reliable representation of spiral ganglion cell 
integrity (Chisolm et al., 2003).  It has been reported that up to half of all neural fibers 
may be lost with little change in hearing thresholds (Pauler, Schuknecht, & Thornton, 
1986), and significant threshold shift may not occur until 90% of nerve fibers are lost 
(Ohlemiller et al., 2008).    
Strial Presbycusis 
The stria vascularis is a highly vascularized epithelium that lines the lateral wall 
of the cochlea and is responsible for maintaining the endocochlear potential (EP) needed 
to drive normal hair cell functioning (Musiek et al., 2007).  Strial presbycusis is caused 
by a degeneration of the stria vasularis which is believed to lead to a reduction in the EP, 
resulting in a hearing loss (Chisolm et al., 2003).  The strial atrophy typically occurs in 
the middle and apical cochlear turns and involves the deterioration of several strial cell 
types (Ohlemiller et al., 2008; Chisolm et al., 2003).  It has been posited that strial ARHL 
is the ‘purest’ form of presbycusis since the degeneration is distinct from pathology that 
may occur due to noise or other cochlear injury (Gratton & Schulte, 1995).  Strial 
presbycusis is characterized by a flat or slightly sloping sensorineural hearing loss with 
well-preserved speech recognition ability (Schuknecht, 1974).  The onset of strial ARHL 
typically occurs in the third to sixth decade of life (Schucknecht, 1964; Pauler, 
Schuknecht & White, 1988; Schuknecht et al., 1993).  Schuknecht reported that strial 
ARHL appeared to have a highly genetic basis, which is supported by ARHL inheritance 
studies (Gates, Couropmitree, & Myers, 1999).  The EP has not been measured in 
humans, and until recently, the most widely accepted animal model of strial presbycusis 
was the Mongolian gerbil (Schulte & Schmiedt, 1992; Gratton et al., 1995; Spicer & 
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Schulte, 2005).  The recent emergence of various mouse models that exhibit 
characteristics of strial ARHL offers an opportunity to further study its pathophysiology 
and potentially uncover responsible genes.   
Anatomy and Physiology of the Cochlear Lateral Wall 
 The stria vascularis is a highly vascularized three-layered structure that runs from 
base to apex, supplying the cochlea with blood and maintaining the +80-90 mV EP 
needed to drive hair cell receptor potentials (Takeuchi, Ando, & Kakigi, 2000).  Normal 
hair cell transduction takes place when mechanically-gated ion channels between 
stereocilia at the top of hair cells open to permit the influx of positively-charged 
endolymph.  This has the effect of depolarizing the normally negatively-charged IHCs 
and OHCs.  Depolarization causes electromotile action in OHCs and firing of auditory 
neurons at the base of IHCs, both essential for normal cochlear functioning.    
The stria vascularis is affixed to the lateral aspect of the cochlear capsule by the 
spiral ligament, which is a connective tissue structure composed of various types (I-V) of 
fibrocyte cells (Santi & Tsuprun, 2001).  Medially, the stria vascularis is contiguous with 
the endolypmhatic space of scala media (Musiek et al., 2007).  The three layers of the 
stria vascularis are made up of three distinct cell types: basal cells which border the spiral 
ligament, intermediate cells, and marginal cells which form the boundary between the 
stria and the endolymph of scala media.     
The stria vascularis is responsible for recycling K+, which is the principle cation 
that contributes to the high EP needed for normal hair cell functioning (Spicer et al., 
2005).  The EP is a direct current electrical potential that exists between the positively 
charged endolymph of scala media and the neutral perilymph of the scala vestibuli and 
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scala tympani (Takeuchi et al., 2000; Wangemann, 2006).  Spicer et al. (2005) have 
described three lateral currents that recover K+ from the hair cells and perilymphatic 
spaces and cycle it back into the endolymph via the spiral ligament and stria vascularis.  
The first recycling route begins in the OHCs, which have used the K+ for depolarization, 
and continues transcellularly through the supporting cells of the organ of Corti to return 
the positively charged ions to the stria (Spicer & Schulte, 1993, 1994a, b, 1996).  A 
second recycling current recovers K+ from scala tympani and scala vestibuli after it has 
been expelled from hair cells and returns it to the stria vascularis via the fibrocyte cells of 
the spiral ligament (Zidanic & Brownell, 1990).  A third recycling route is believed to 
transmit K+ from scala media and scala tympani, returning it to the stria vascularis 
through the cells in the spiral ligament (Spicer, Smythe, & Schulte, 2003).  Figure 1 
illustrates the general pathways of K+ as it is recycled by the stria vascularis.  Once K+ is 
returned to the stria vascularis, several important ion channels are involved in generating 
the EP.  The Kcnj10 channel moves K+ through the intermediate cells, and the Na
+
/K
+
-
ATPase and Na
+
K
+
/Cl
-
 co-transporter channels are responsible for moving K+ through 
the marginal cells (Wangemann, 2006; Crouch, Sakaguchi, Lytle, & Schulte, 1997).   
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          Figure 1. Lateral K+ recycling currents of the stria vascularis.  (Used with permission) 
 
 
 
The stria vascularis contains a dense network of capillaries and has a high 
metabolic demand due to its role in endolymph production.  One possible etiology 
underlying strial presbycusis is microvascular dysfunction involving capillary loss and 
the thickening of capillary basement membranes (Johnsson & Hawkins, 1972; Gratton, 
Schmiedt, & Schulte, 1996).  Although microvascular degeneration may be responsible 
for some cases of strial presbycusis, human temporal bone studies suggest that marginal 
cell pathology is the dominant cause of human strial presbycusis (Schuknecht, 1974).  
Applicable animal models, including the Mongolian gerbil and BALB/cJ mouse also 
exhibit an age-related decline in the number of marginal cells and an associated decrease 
in the EP (Schulte et al., 1992; Spicer et al., 2005; Ohlemiller Lett, & Gagnon, 2006).  In 
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both humans and animals, 30 to 40% of the stria may degenerate before changes in 
hearing sensitivity occur (Pauler et al., 1988).   
Strial Presbycusis in the Mongolian Gerbil 
Although many animals exhibit some aspects of strial pathology, the Mongolian 
gerbil has been the most widely-used model of human strial presbycusis (Ohlemiller et 
al., 2008).  It is thought that most of the ARHL that occurs in this species can be 
attributed to strial degeneration and a reduction in the EP (Schulte et al., 1992; Gratton et 
al., 1995; Spicer et al., 2005).  Strial atrophy has been shown to begin in the secondary 
processes of marginal cells and spread to the primary processes which project from the 
apical cell bodies of marginal cells (Spicer et al., 2005).  Because of the genetic 
heterogeneity of the Mongolian gerbil, this model is not well-suited for research 
attempting to isolate the genetic factors responsible for strial presbycusis (Ohlemiller et 
al., 2008).  This drawback can be remedied through the application of mouse models of 
strial ARHL which facilitate genetic analysis through comparison with other readily-
available inbred mouse strains.   
Advantages of Mouse Models  
Mice are an attractive model for ARHL for many reasons that include a genetic 
similarity to humans and the genetic homogeneity within strains.  Information gathered 
about the mice genome can be applied to humans because mice and humans share a great 
number of similar genes or homologs; in fact, approximately 80% of all human and 
mouse genes are orthologous, meaning that they were inherited from a common ancestor 
(Griffiths, Wessler, Lewontin, & Carroll, 2008).  Many mutually-inherited orthologous 
genes retain their original biologic function in the various species that inherit them 
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(Remm, Storm, & Sonhammer, 2001), which allows for direct genetic comparison 
between mice and humans.  Mice models also offer practical advantages for hearing 
research such as their short life span, which reduces housing costs, and the fact that they 
have a great capacity for genetic standardization (Ohlemiller, 2006).   
Strial Presbycusis in Mice 
Until recently, the Mongolian gerbil was the only animal model known to exhibit 
the hallmark strial presbycusis features of strial degeneration starting with marginal cells 
and an associated reduction in the EP.  Unlike the Mongolian gerbil, mice offer a 
multitude of inbred strains, which facilitates genetic analysis through the comparison of 
physical traits in strains with distinctly different genetic backgrounds (Ohlemiller et al., 
2008).  A 2006 study by Ohlemiller et al. identified BALB/cJ (BALB) mice as the first 
naturally-occurring mouse model of strial presbycusis for which a clear anatomic 
correlate could be found.  Reduction in the EP of BALBs by 19 months of age 
corresponded to a decline in marginal cell numbers.  In addition to the degeneration of 
marginal cells, a thinning of the spiral ligament was noted with age in BALB mice.  A 
significant feature of the study was that the EP and cochlear lateral wall anatomical 
measures in BALB mice and C57BL/6J (B6) mice were compared side by side.  In 
contrast to BALBs, the B6 mice maintained a stable EP throughout their lifespan that 
corresponded to a stable marginal cell population and a thicker spiral ligament.  Figure 2 
illustrates the fact that young B6 mice begin life with higher numbers of marginal cells 
and a thicker spiral ligament compared to age-matched BALB mice.  In addition to the 
differences observed at a young age, B6 mice maintain a stable EP, a higher density of 
marginal cells, and a thicker spiral ligament throughout the lifespan compared to BALB 
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mice, which can be seen in Figure 3.  Marginal cell density and spiral ligament thickness 
were significantly correlated with the EP in both young and old BALB mice.  The 
existence of two usefully-differing mouse strains lends itself to investigation of the 
genetics underlying strial ARHL using recombinant inbred mouse strains, which is the 
basis of the present study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Figure 2. Typical upper basal lateral wall in BALB and B6 mice  
          (Ohlemiller et al., 2006).  Arrows indicate location of marginal cells. 
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Figure 3. EP versus age for BALB and B6 mice.  BALBs begin life with  
               lower ‘normal’ EP and are more likely to exhibit EP decline 
               (Ohlemiller, 2006). 
 
 
Pursuing the Genetics of Strial Presbycusis using Recombinant Inbred Strains 
 The fact that BALB and B6 mouse strains usefully differ in terms of the EP and 
cochlear lateral wall attributes offers the possibility of using recombinant inbred (RI) 
mouse strains to investigate the genetic components responsible for these differences.  
Key to this innovation is the commercial development and availability of RI strains 
formed from BALB and B6.  RI strains are created by crossing random offspring from 
two parent or progenitor strains, then intentionally generating sub-lines from a large 
number of F1 mating pairs.  Each RI strain is rendered inbred through repeated sibling 
mating over 20 or more generations; this yields RI strains that are genetically different 
from one another, but essentially identical within any RI strain (Bailey, 1971).  A set of 
RI strains derived from the same progenitor strains can be used to detect linkages 
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between a phenotype (i.e., endocochlear potential or lateral wall metrics) and previously 
mapped marker loci in the mouse genome (Neumann, 1992).  Marker loci are 
molecularly distinct regions of chromosomes spread throughout the genome specifically 
chosen because they are polymorphic between the parent strains.  Thus all the RI strains 
in a series will carry unique combinations of traits and adjacent markers that can be typed 
for one of the parent strains.  Accordingly, the strain distribution pattern (SDP) for a trait 
can be expected to match the SDP of a known marker, permitting coarse mapping of the 
trait.  Typically one may obtain a location known to derive from only one of the two 
parent strains that contains a chromosomal region that correlates with a trait of interest.  
Since the actual gene and gene product will frequently remain unknown, the region is 
referred to as quantitative trait locus (QTL), and is simply named for the trait itself 
(Alberts & Schughart, 2010).  Growing sets of strain-dependent marker locations in 
established RI strains are continually updated in online repositories.  A typical analysis 
entails phenotyping as many members of an RI series as possible, then entering the SDP 
into an online mapping utility such as WebQTL, which calculates the statistical 
phenotype-genotype association (Wang, Williams, & Manly, 2003).  The identification of 
QTLs for the phenotype of interest allows researchers to pursue candidate genes that 
regulate the trait using traditional mapping and gene array methods. 
Present Study 
 The fact that BALB and B6 mouse strains differ in terms of both the EP and 
cochlear lateral wall attributes suggests that they possess different alleles at one or more 
loci that control these features.  Fortunately, there is a well-established RI strain set, the 
CxB series, which is formed from genetic crosses of BALB and B6 mice, facilitating 
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genetic linkage analysis of measureable traits.  There are 13 members of the CxB series, 
denoted CxB1–CxB13.  Each CxB strain carries a random assortment of the BALB and 
B6 genomes, but is homozygous at essentially all gene loci.  The number of strains that 
exhibit either BALB or B6 characteristics can be used to estimate the minimum number 
of genes that regulate the EP and anatomical correlates (Bailey, 1971).  For example, 
from simple Mendelian principles, if roughly half the RI strains possess a BALB-like 
phenotype, it would suggest that primarily one gene loci shapes the trait.  If two genes are 
largely and equally responsible for the ‘BALB EP’ phenotype, approximately one quarter 
of the RI strains would be expected to inherit these genes and the associated phenotype.  
In pilot experiments conducted by the Ohlemiller laboratory in 2010, the EP was 
measured in 12 of 13 commercial CxB RI strains to establish the SDP for ‘normal’ EP 
across these RI strains.  Figure 4 illustrates the distribution of mean EP for each of these 
12 RI strains.  Results revealed two strains (CxB5 & CxB11) that exhibited a clearly 
‘BALB-like’ EP (≤ 105 mV), suggesting that two or more genes are responsible for the 
‘BALB EP’ phenotype. 
The present study was undertaken to further investigate the pathophysiology of 
strial presbycusis and to potentially identify responsible genes.  The histopathology of 
strial ARHL was explored by comparing anatomical measures of stria vascularis and 
spiral ligament integrity to the EP measured across 11 members of the CxB series.  
Investigation of the potential gene(s) responsible for strial presbycusis was conducted by 
performing genetic linkage analysis using the cochlear lateral wall metrics and EP 
measurements.   
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                Figure 4. Mean EP ordered across 12 RI strains, reflecting effect of random  
                combinations of B6 and BALB alleles on EP.  (Ohlemiller, 2010, unpublished). 
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CHAPTER 2 
 
 
METHODS 
 
 
All procedures were approved by the Washington University Institutional Animal 
Care and Use Committee.  The sample consisted of 11 of 13 RI strains (CxB1-CxB13) 
available from The Jackson Laboratory.  The CxB13 strain was not analyzed due to 
significant middle ear pathology, and the CxB8 strain and F1s have not yet been 
analyzed.  Mice included both genders and ranged from 2-4 months in age (typical life 
span of ~24 months).  Young mice were examined in this study because the two 
progenitor strains (BALB and B6) are known to differ in terms of the EP and anatomical 
correlates even at a young age (Ohlemiller, 2006).  The EP was measured in 6 mice from 
each strain.  A fine drill was used to make a hole directly over scala media in the lower 
basal turn of left cochleae.  Glass capillary pipettes (40-80 MX) filled with 0.15 MKCl 
were advanced into scala media until a stable positive potential was observed that did not 
change with increased electrode depth.  Left cochleae were embedded in Epon plastic and 
sectioned in the mid-modiolar plane.  Fifty 4 μm sections were obtained from each 
cochlea, spanning 200 μm through the mid-modiolar core.  Ten sections were analyzed 
for each mouse.  Analysis of cochlear metrics (strial thickness, marginal cell density, and 
spiral ligament thickness) was completed in three locations:  lower base, upper base, and 
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lower apex.  Marginal cells were counted in an 80 μm linear segment of the stria 
vascularis centered at the midpoint.  Strial thickness was measured orthogonal to the 
midpoint.  Spiral ligament thickness was measured on an axis co-linear with the strial 
midline.  Cochlear metrics were obtained using a Nikon Optiphot™ light microscope 
with a 100x oil objective and a calibrated grid ocular.   
Overall means for each cochlear metric were calculated by averaging the ten 
estimates for each animal.  Linear correlations were calculated between EP and each 
strial metric (strial thickness, marginal cell density, and spiral ligament thickness) for B6, 
BALB, and 11 RI strains.  Strial metrics were focused on the upper basal turn.  For all 
correlations, a regression slope significantly different from zero was taken to denote a 
statistically significant difference between groups.  Cochlear metric and EP 
measurements taken across the 11 RI strains yielded SDPs of each phenotype.  
Quantitative trait locus (QTL) mapping was performed by analyzing the SDPs for each 
phenotype (EP and cochlear metrics) using WebQTL to investigate statistical association 
between phenotype values and genotypes of marker loci.   
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CHAPTER 3 
 
 
RESULTS 
 
 
None of the strial metrics (strial thickness, marginal cell density, and spiral 
ligament thickness) were significantly correlated with the EP across the 11 RI strains 
(Fig. 5).  Figure 5 shows correlations between the EP and each strial metric and illustrates 
the fact that the relationship between marginal cell density and the EP approached 
significance (p < .06).   
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Figure 5. EP versus three strial metrics in 11 of 13 RI strains 
plus B6 and BALB. None were significantly correlated with 
EP, although relation to marginal cell density is suggested.  
F1s, CxB8, and CxB13 have not been analyzed. 
 
 20 
 
Anaylsis of the SDP for EP using the online mapping utility WebQTL revealed a 
‘suggestive’ association [log of odds (LOD) score > 4.12] with a segment of 
Chromosome 12.  Figure 6 shows the likelihood of association between the EP and 
genetic loci on each mouse chromosome, with the ‘suggestive’ association on 
Chromosome 12.  Since one or more genes within this region appear to be involved in 
regulating the EP, this QTL was provisionally named Nvep1 to denote ‘normal variation 
in EP’.  A suggestive locus was also revealed on Chromosome 15, which was 
provisionally named Nvep2.  Figure 7 shows an expanded view of the Nvep1 region, 
which revealed that the locus encompasses a ~7Mb section of Chromosome 12.   
 
 
      Figure 6. Analysis of EP data using WebQTL online mapping utility revealed ‘suggestive’ linkage 
        to a segment of Chromosome 12 (provisionally named Nvep1) and suggestive locus on  
       Chr. 15 (Nvep2). 
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       Figure 7. Expanded view of Nvep1 region revealed a ‘suggestive’ log of odds (LOD) score (> 4.12)  
       for EP and ~7Mb segment of Chromosome 12 . 
 
 
Anaylsis of the SDP for marginal cell density also revealed a ‘suggestive’ 
association with the same region of Chromosome 12.  Figure 8 illustrates the likelihood 
of association between the SDP for marginal cell density and each mouse chromosome, 
displaying the ‘suggestive’ association between marginal cell density and Chromosome 
12.  An expanded view of the Nvep1 region, shown in Figure 9, revealed that the 
marginal cell SDP maps to the same ~7Mb segment of Chromosome 12 as did the SDP 
for EP.   
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        Figure 8. Analysis of marginal cell data using WebQTL revealed significant linkage to same  
        ~7Mb segment of Chr. 12 (Nvep1). 
 
 
        Figure 9. Expanded view reveals Chr. 12 ‘suggestive’ log of odds (LOD) score (>1.75) for  
        marginal cell data that aligns with the ~7mB segment of Nvep1. 
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CHAPTER 4 
 
 
DISCUSSION 
 
 
The overlapping QTLs associated with EP and marginal cell density offer support 
for the suggestion that subtle differences in marginal cell density (or a related property) in 
part determine the EP.  Additional support comes from the fact that the correlation 
between the EP and marginal cell density approached significance (p < .06).  This 
relation has been observed in human temporal bone and animal studies (Schuknecht, 
1974; Ohlemiller et al., 2006; Spicer et al., 2005).  The provisional QTLs, Nvep 1 and 
Nvep 2, are the first loci that appear to modulate the EP within the normal range.  Since 
marginal cell density corresponds to both the ‘low normal’ EP in young BALBs as well 
as age-associated EP decline in BALBs, the Nvep1 region may encompass a ‘strial 
presbycusis’ predisposing gene.   
The findings of this study are consistent with both human temporal bone and 
Mongolian gerbil studies.  In his study of human temporal bones, Schuknecht (1974) 
observed that the degeneration of the stria appeared to begin with pathology of the 
marginal cells.  Likewise, studies involving the Mongolian gerbil have revealed that the 
hearing loss observed in these animals is attributable to strial pathology, with cell death 
beginning with the marginal cells and involving other lateral wall cell types with time.  
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The findings of the present study, which revealed a suggestive linkage between a segment 
of Chromosome 12 (Nvep 1) with both marginal cell density and the EP offers further 
support for an association between marginal cell health and the EP.  Although hearing 
threshold shift was not measured in mice from the present study, the anatomical and EP 
measurements agree well with the findings of previous studies (human temporal bones 
and Mongolian gerbil) which exhibited similar strial pathology and hearing loss.  This 
agreement supports the fact that the BALB mouse is an appropriate model for strial 
presbycusis. 
Potential limitations of the study include using cell counts from a single cochlear 
location to represent the integrity of the cochlea as a whole, and using only young mice.  
Future studies may involve examination of aging mice from the CxB sRI strains to 
determine whether the differences in EP and marginal cell density persist throughout the 
lifespan.  The relationship between the cochlear lateral wall metrics (strial thickness, 
marginal cell density, and spiral ligament thickness) may become more obvious in older 
mice with more pronounced age-related strial pathology.  Additionally, due in part to the 
relatively small set of CxB RI strains, the suggested QTLs must be confirmed using 
additional methods.  The discovery of Nvep1 and Nvep2 paves the way for future studies 
aimed at determining the specific genes responsible for strial presbycusis.  In particular, a 
future study may involve the creation of two congenic strains, each for one QTL that can 
be used to reduce the QTL interval for better isolation of candidate genes.  Within the 
present interval for Nvep1 are 48 known genes, each of which can be evaluated using 
online data bases for known polymorphisms between BALB and B6 mice.  
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If Nvep1 does indeed constitute a ‘strial presbycusis predisposing’ gene, its 
human homolog may operate in the same manner.  It might thus be possible to identify 
clinical populations that would be considered at-risk for strial presbycusis.  This might 
facilitate audiologic and/or medical treatment that is tailored to the underlying pathology 
of strial presbycusis.  For example, the fact that individuals with strial presbycusis are 
thought to have well-preserved word recognition might influence an audiologist’s 
prediction of hearing aid benefit or assist in the selection of a hearing aid fitting strategy.  
Strial presbycusis may also one day be corrected medically by an inner ear implantable 
device that restores the normal +80mV EP in the human cochlea.  Such a device has been 
shown to be temporarily successful in improving thresholds in Mongolian gerbils with 
strial presbycusis by injecting positive current into scala media with an electrode 
(Schmiedt, 1993).  In order to be a viable option for humans, this device faces the 
challenges of finding an electrode-insertion method that minimizes damage to the sensory 
structures of scala media and is able to maintain the DC voltage in the fluid-filled 
cochlea.   
A more desirable alternative to a prosthetic device is a solution that repairs the 
cells involved in maintaining the EP.  For example, strial presbycusis might one day be 
amenable to correction through gene therapy that would replace defective gene(s) in 
order to restore the function of cells involved in K+ recycling.  Gene therapy may one 
day be used to introduce healthy genes into the bloodstream or respiratory system that 
would express themselves in the inner ear and correct strial presbycusis.  While it is 
currently very difficult to separate the various forms of ARHL based on audiometric 
results, genetic testing offers the promise of an objective test that could provide 
 26 
differential diagnosis and treatment options for strial ARHL.  Regardless of whether gene 
therapy for strial ARHL becomes a reality, genetic hearing research using mouse models 
provides invaluable information about the pathophysiology of strial presbycusis, which 
will improve audiologic rehabilitation for the growing aging population in the future. 
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